☰

Peter R. Byron - Publications

Affiliations: 
Virginia Commonwealth University, Richmond, VA, United States 
Area:
Pharmaceutical Chemistry, Pharmacy
Website:
https://news.pharmacy.vcu.edu/2015/01/12/pceus-changing-of-the-guard/
Tree Info Similar researchers PubMed Report error

44 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Wei X, Hindle M, Kaviratna A, Huynh BK, Delvadia RR, Sandell D, Byron PR. In Vitro Tests for Aerosol Deposition. VI: Realistic Testing with Different Mouth-Throat Models and In Vitro-In Vivo Correlations for a Dry Powder Inhaler, Metered Dose Inhaler, and Soft Mist Inhaler. Journal of Aerosol Medicine and Pulmonary Drug Delivery. PMID 29878859 DOI: 10.1089/Jamp.2018.1454  0.627
2017 Wei X, Hindle M, Delvadia RR, Byron PR. In Vitro Tests for Aerosol Deposition. V: Using Realistic Testing to Estimate Variations in Aerosol Properties at the Trachea. Journal of Aerosol Medicine and Pulmonary Drug Delivery. PMID 28332899 DOI: 10.1089/jamp.2016.1349  0.625
2015 Gomez-Arroyo J, Sakagami M, Syed AA, Farkas L, Van Tassell B, Kraskauskas D, Mizuno S, Abbate A, Bogaard HJ, Byron PR, Voelkel NF. Iloprost reverses established fibrosis in experimental right ventricular failure. The European Respiratory Journal. 45: 449-62. PMID 25261325 DOI: 10.1183/09031936.00188013  0.642
2013 Li M, Byron PR. Tobramycin disposition in the rat lung following airway administration. The Journal of Pharmacology and Experimental Therapeutics. 347: 318-24. PMID 24008335 DOI: 10.1124/Jpet.113.207415  0.379
2013 Delvadia RR, Longest PW, Hindle M, Byron PR. In vitro tests for aerosol deposition. III: effect of inhaler insertion angle on aerosol deposition. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 26: 145-56. PMID 23025452 DOI: 10.1089/Jamp.2012.0989  0.62
2013 Delvadia R, Hindle M, Longest PW, Byron PR. In vitro tests for aerosol deposition II: IVIVCs for different dry powder inhalers in normal adults. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 26: 138-44. PMID 22947131 DOI: 10.1089/Jamp.2012.0975  0.618
2012 Delvadia RR, Longest PW, Byron PR. In vitro tests for aerosol deposition. I: Scaling a physical model of the upper airways to predict drug deposition variation in normal humans. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 25: 32-40. PMID 22070526 DOI: 10.1089/Jamp.2011.0905  0.351
2011 Werley MS, McDonald P, Lilly P, Kirkpatrick D, Wallery J, Byron P, Venitz J. Non-clinical safety and pharmacokinetic evaluations of propylene glycol aerosol in Sprague-Dawley rats and Beagle dogs. Toxicology. 287: 76-90. PMID 21683116 DOI: 10.1016/J.Tox.2011.05.015  0.35
2010 Byron PR, Hindle M, Lange CF, Longest PW, McRobbie D, Oldham MJ, Olsson B, Thiel CG, Wachtel H, Finlay WH. In vivo-in vitro correlations: predicting pulmonary drug deposition from pharmaceutical aerosols. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 23: S59-69. PMID 21133801 DOI: 10.1089/Jamp.2010.0846  0.631
2009 Kotian R, Peart J, Bryner J, Byron PR. Calibration of the modified Electrical Low-Pressure Impactor (ELPI) for use with pressurized pharmaceutical aerosols. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 22: 55-65. PMID 18954291 DOI: 10.1089/Jamp.2008.0683  0.319
2009 Kamiya A, Sakagami M, Byron PR. Cascade impactor practice for a high dose dry powder inhaler at 90 L/min: NGI versus modified 6-stage and 8-stage ACI. Journal of Pharmaceutical Sciences. 98: 1028-39. PMID 18661538 DOI: 10.1002/Jps.21501  0.669
2007 Byron PR, Dalby RN, Peart J. Respiratory Drug Delivery Europe 2007. Expert Review of Respiratory Medicine. 1: 39-41. PMID 20477264 DOI: 10.1586/17476348.1.1.39  0.303
2007 Pang Y, Sakagami M, Byron PR. Insulin self-association: effects on lung disposition kinetics in the airways of the isolated perfused rat lung (IPRL). Pharmaceutical Research. 24: 1636-44. PMID 17476466 DOI: 10.1007/S11095-007-9292-6  0.74
2007 Patton JS, Byron PR. Inhaling medicines: delivering drugs to the body through the lungs. Nature Reviews. Drug Discovery. 6: 67-74. PMID 17195033 DOI: 10.1038/Nrd2153  0.37
2007 Longest PW, Hindle M, Choudhuri SD, Byron PR. Numerical simulations of capillary aerosol generation: CFD model development and comparisons with experimental data Aerosol Science and Technology. 41: 952-973. DOI: 10.1080/02786820701607027  0.624
2005 Li X, Blondino FE, Hindle M, Soine WH, Byron PR. Stability and characterization of perphenazine aerosols generated using the capillary aerosol generator. International Journal of Pharmaceutics. 303: 113-24. PMID 16139453 DOI: 10.1016/J.Ijpharm.2005.07.010  0.712
2005 Pang Y, Sakagami M, Byron PR. The pharmacokinetics of pulmonary insulin in the in vitro isolated perfused rat lung: implications of metabolism and regional deposition. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 25: 369-78. PMID 15979534 DOI: 10.1016/J.Ejps.2005.03.010  0.759
2005 Hou S, Hindle M, Byron PR. Chromatographic and mass spectral characterization of budesonide and a series of structurally related corticosteroids using LC-MS. Journal of Pharmaceutical and Biomedical Analysis. 39: 196-205. PMID 15925469 DOI: 10.1016/J.Jpba.2005.03.026  0.722
2005 Sakagami M, Byron PR. Respirable microspheres for inhalation: the potential of manipulating pulmonary disposition for improved therapeutic efficacy. Clinical Pharmacokinetics. 44: 263-77. PMID 15762769 DOI: 10.2165/00003088-200544030-00004  0.684
2004 Kamiya A, Sakagami M, Hindle M, Byron PR. Aerodynamic sizing of metered dose inhalers: an evaluation of the Andersen and Next Generation pharmaceutical impactors and their USP methods. Journal of Pharmaceutical Sciences. 93: 1828-37. PMID 15176070 DOI: 10.1002/Jps.20091  0.743
2004 Shen X, Hindle M, Byron PR. Effect of energy on propylene glycol aerosols using the capillary aerosol generator. International Journal of Pharmaceutics. 275: 249-58. PMID 15081155 DOI: 10.1016/J.Ijpharm.2004.02.005  0.722
2003 Gupta R, Hindle M, Byron PR, Cox KA, McRae DD. Investigation of a Novel Condensation Aerosol Generator: Solute and Solvent Effects Aerosol Science and Technology. 37: 672-681. DOI: 10.1080/02786820300910  0.589
2002 Hong JN, Hindle M, Byron PR. Control of particle size by coagulation of novel condensation aerosols in reservoir chambers. Journal of Aerosol Medicine : the Official Journal of the International Society For Aerosols in Medicine. 15: 359-68. PMID 12581502 DOI: 10.1089/08942680260473434  0.618
2002 Sakagami M, Byron PR, Rypacek F. Biochemical evidence for transcytotic absorption of polyaspartamide from the rat lung: effects of temperature and metabolic inhibitors. Journal of Pharmaceutical Sciences. 91: 1958-68. PMID 12210043 DOI: 10.1002/Jps.10188  0.681
2002 Sakagami M, Byron PR, Venitz J, Rypacek F. Solute disposition in the rat lung in vivo and in vitro: determining regional absorption kinetics in the presence of mucociliary escalator. Journal of Pharmaceutical Sciences. 91: 594-604. PMID 11835216 DOI: 10.1002/Jps.10069  0.682
2001 Hou S, Hindle M, Byron PR. A stability-indicating HPLC assay method for budesonide. Journal of Pharmaceutical and Biomedical Analysis. 24: 371-80. PMID 11199216 DOI: 10.1016/S0731-7085(00)00424-6  0.74
2000 Vervaet C, Byron PR. Polystyrene microsphere spray standards based on CFC-free inhaler technology. Journal of Aerosol Medicine : the Official Journal of the International Society For Aerosols in Medicine. 13: 105-15. PMID 11010591 DOI: 10.1089/089426800418631  0.319
1999 Vervaet C, Byron PR. Drug-surfactant-propellant interactions in HFA-formulations. International Journal of Pharmaceutics. 186: 13-30. PMID 10469920 DOI: 10.1016/S0378-5173(99)00134-9  0.341
1999 Sun JZ, Byron PR, Rypacek F. Solute absorption from the airways of the isolated rat lung. V. Charge effects on the absorption of copolymers of N(2-hydroxyethyl)-DL-aspartamide with DL-aspartic acid or dimethylaminopropyl-DL-aspartamide. Pharmaceutical Research. 16: 1104-8. PMID 10450938 DOI: 10.1023/A:1018904320525  0.331
1997 Byron PR, Peart J, Staniforth JN. Aerosol electrostatics. I: Properties of fine powders before and after aerosolization by dry powder inhalers. Pharmaceutical Research. 14: 698-705. PMID 9210184 DOI: 10.1023/A:1012181818244  0.312
1995 Hindle M, Byron PR. Dose emissions from marketed dry powder inhalers International Journal of Pharmaceutics. 116: 169-177. DOI: 10.1016/0378-5173(94)00287-F  0.56
1994 Phillips EM, Byron PR. Surfactant promoted crystal growth of micronized methylprednisolone in trichloromonofluoromethane International Journal of Pharmaceutics. 110: 9-19. DOI: 10.1016/0378-5173(94)90370-0  0.336
1993 Byron PR. Physicochemical Effects on Lung Disposition of Pharmaceutical Aerosols Aerosol Science and Technology. 18: 223-229. DOI: 10.1080/02786829308959599  0.368
1991 Dalby RN, Phillips EM, Byron PR. Determination of drug solubility in aerosol propellants. Pharmaceutical Research. 8: 1206-9. PMID 1788170 DOI: 10.1023/A:1015827023504  0.337
1990 Phillips EM, Byron PR, Fults K, Hickey AJ. Optimized inhalation aerosols. II. Inertial testing methods for particle size analysis of pressurized inhalers. Pharmaceutical Research. 7: 1228-33. PMID 2095559 DOI: 10.1023/A:1015973402316  0.334
1989 Niven RW, Byron PR. Solute absorption from the airways of the isolated rat lung. I. The use of absorption data to quantify drug dissolution or release in the respiratory tract. Pharmaceutical Research. 5: 574-9. PMID 3247320 DOI: 10.1023/A:1015942013413  0.391
1989 Byron PR, Niven RW. A novel dosing method for drug administration to the airways of the isolated perfused rat lung. Journal of Pharmaceutical Sciences. 77: 693-5. PMID 3210159 DOI: 10.1002/Jps.2600770810  0.396
1981 Byron PR, Guest RT, Notari RE. Thermodynamic dependence of interfacial transfer kinetics of nonionized barbituric acid derivatives in two-phase transfer cell. Journal of Pharmaceutical Sciences. 70: 1265-9. PMID 7299674 DOI: 10.1002/Jps.2600701121  0.595
1980 Byron PR, Notari RE, Tomlinson E. Calculation of partition coefficient of an unstable compound using kinetic methods. Journal of Pharmaceutical Sciences. 69: 527-31. PMID 7381736 DOI: 10.1002/Jps.2600690513  0.618
1980 Tomlinson E, Notari RE, Byron PR. Simultaneous partitioning and hydrolysis kinetics of amoxicillin and ampicillin. Journal of Pharmaceutical Sciences. 69: 655-8. PMID 7205576 DOI: 10.1002/Jps.2600690612  0.596
1978 Byron PR, Notari RE, Tomlinson E. Calculation of the partition coefficient of an unstable compound using kinetic methods [proceedings]. The Journal of Pharmacy and Pharmacology. 30: 7P. PMID 32328 DOI: 10.1111/J.2042-7158.1978.TB10714.X  0.58
1978 Notari RE, Mei-Ying H, Byron PR. Calculations of optimum pharmacokinetic drug supply rates for maximum duration during multiple dose therapy by prodrug administration International Journal of Pharmaceutics. 1: 233-247. DOI: 10.1016/0378-5173(78)90012-1  0.628
1978 Byron PR, Notari RE, Mei-Ying H. Pharmacokinetic predictions of optimum drug delivery rates from prodrugs designed for maximum duration International Journal of Pharmaceutics. 1: 219-231. DOI: 10.1016/0378-5173(78)90011-X  0.629
1976 Byron PR, Notari RE. Critical analysis of "flip-flop" phenomenon in two-compartment pharmacokinetic model. Journal of Pharmaceutical Sciences. 65: 1140-4. PMID 978432  0.615
Show low-probability matches.